Applications of the mouse foot edema test in evaluation of anti-cholera drugs.
D000818:Animals; D000890:Anti-Infective Agents; D001241:Aspirin / Q000627:therapeutic use; D002701:Chloramphenicol / Q000627:therapeutic use; D002771:Cholera / Q000188:drug therapy*; D003513:Cycloheximide / Q000627:therapeutic use; D003609:Dactinomycin / Q000627:therapeutic use; D004232:Diuretics / Q000627:therapeutic use; D004487:Edema / Q000139:chemically induced*; D004640:Emetine / Q000627:therapeutic use; D004768:Enterotoxins / Q000037:antagonists & inhibitors; D004976:Ethacrynic Acid / Q000627:therapeutic use; D005215:Fasting; D005665:Furosemide / Q000627:therapeutic use; D007213:Indomethacin / Q000627:therapeutic use; D007490:Iproniazid / Q000627:therapeutic use; D015122:Mercaptopurine / Q000627:therapeutic use; D051379:Mice; D008954:Models, Biological; D010653:Phenylbutazone / Q000627:therapeutic use; D014176:Protein Biosynthesis; D011691:Puromycin / Q000627:therapeutic use; D013997:Time Factors; D014221:Triamcinolone / Q000627:therapeutic use
D000890:Anti-Infective Agents; D004232:Diuretics; D004768:Enterotoxins; D003609:Dactinomycin; D014221:Triamcinolone; D011691:Puromycin; D002701:Chloramphenicol; D005665:Furosemide; D003513:Cycloheximide; D007490:Iproniazid; D015122:Mercaptopurine; D010653:Phenylbutazone; D004976:Ethacrynic Acid; D001241:Aspirin; D004640:Emetine; D007213:Indomethacin